Author:
Varbanova Boriana B.,Dyankov E. D.
Reference23 articles.
1. Wijnands M J H, Van’t Hof M A, L.B.A. van de Putte et al. Rheumatoid arthritis: A risk factor for sulphasalazine toxicity? A meta-analysis. Brit J Rheumatol, 32, 313–318. (1993)
2. Porter D R, Mclnnes I B, Hunter J et al. Outcome of second line therapy in rheumatoid arthritis. Ann Rheum Dis, 53, 812–815. (1994)
3. Farr L F, Palmer R.G., Bacon P.A.. Sulphasalazine in rheumatoid arthritis; Long term tolerability in 432 patients monitored for 2 to 15 years. Arthritis Rheum, 37, 578 abstr. (1994)
4. Van Riel P L C M, van Gestel A.M., Prevoo M.L.L. et al. Long term experience with sulphasalazine in a cohort of early rheumatoid arthritis patients. Arthritis Rheum, 37, 579 abstr. (1994)
5. Wijnands M J H, Van’t Hof M.A., van Leeuwen M.A. et al. Long term second-line treatment: A prospective drug “survival” study. EULAR-bulletin, 1993, 1,10–14.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献